Miami Cancer Institute
Coverage of Miami Cancer Institute in the Nexus archive.
- New cancer tech sends chemo straight to tumors
A new cancer technology called Trans-Arterial Micro-Perfusion (TAMP) is being studied in a Phase III clinical trial for locally advanced pancreatic cancer, delivering chemotherapy directly near the tumor instead of through the entire body. This approach may reduce side effects and improve treatment outcomes. The system uses a catheter placed in an artery near the tumor to deliver chemotherapy.
- Shift in cancer screening guidance has experts clashing over new guidance
The American College of Physicians has released new guidance for breast cancer screening, recommending that average-risk women between 50 and 74 years old undergo mammograms every two years. Women between 40 and 49 years old are encouraged to discuss their risk with a doctor. The guidance aims to reduce unnecessary screening and potential harms.
- Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug
Former U.S. Senator Ben Sasse, diagnosed with stage 4 metastatic pancreatic cancer, reports a 76% tumor reduction after participating in a clinical trial for the experimental drug daraxonrasib. Developed by Revolution Medicines, the therapy targets the RAS gene in pancreatic cancer, showing median survival of 13 months in trials compared to 6 months with standard chemotherapy.